Matthew W. Davis Aquestive Therapeutics, Inc. (AQST) insider trading activity

AQST Quotes by TradingView

Matthew W. Davis is Chief Development Officer of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 50,000 shares of AQST, which is worth approximately $269,500. The most recent transaction as insider was on Nov 10, 2025, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50K
n/a 3M change
n/a 12M change
Total Value Held $269,500

Matthew W. Davis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 10 2025
BUY
Grant, award, or other acquisition
-
50,000 Added 50.0%
50,000 Common Stock
MWD

Matthew W. Davis

Chief Development Officer
Warren, NJ

Track Institutional and Insider Activities on AQST

Follow Aquestive Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

News

Receive news related to Aquestive Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AQST